AAVantgarde Bio
ItalyEntry
2025
Hold
1yr
Status
Active
Who owns AAVantgarde Bio?
AAVantgarde Bio is an Italian Biotech company, currently owned by Athos since 2025 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
CDP Venture Capital SGRLarge Ventures · 2022 · VC
4 ownership periods · full history below
Key facts
HQItaly
SectorBiotech
Key takeaways
- ·Co-held by Sofinnova Partners, Athos, Neva SGR and CDP Venture Capital SGR since 2020.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Telethon · 2016 · Life Sciences VC
CDP Venture Capital SGRActive
2025 · present(1yr) · Large Ventures · 2022 · VC
Neva SGRActive
2025 · present(1yr) · Neva First · 2020 · VC
AthosActive
2025 · present(1yr) · Athos Evergreen Life Sciences · 2001 · Evergreen
More from Large Ventures
Other portfolio companies in the same fund.
Germany
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns AAVantgarde Bio?
AAVantgarde Bio is currently owned by Athos, Neva SGR and 2 others, through Large Ventures, since 2025.
When did Athos and 3 others acquire AAVantgarde Bio?
Athos and 3 others acquired AAVantgarde Bio in 2025.
Who has owned AAVantgarde Bio over time?
AAVantgarde Bio has been through 4 private-equity ownership periods: Sofinnova Partners · via Sofinnova Telethon · since 2020; Athos · via Athos Evergreen Life Sciences · since 2025; Neva SGR · via Neva First · since 2025; CDP Venture Capital SGR · via Large Ventures · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue